Clinical Edge Journal Scan

Single-port laparoscopy myomectomy feasible for treatment of uterine fibroids


 

Key clinical point: Single-port laparoscopic myomectomy (LM) for treatment of uterine fibroids (UF) showed characteristics of lesser trauma, faster recovery, and higher patient satisfaction than the traditional 3-port LM.

Major finding: The specimen removal time, postoperative ambulation time, first exhaust time after surgery, and postoperative hospital stay were lower for single-port vs traditional 3-port LM (all P < .05). After 30 days of operation, the abdominal scar satisfaction score was higher in the single-port vs 3-port LM group (4.17 vs 3.47; P = .00). Intraoperative blood loss was similar in both groups ( P > .05).

Study details: Findings are from a retrospective review of 120 patients with UFs who underwent LM. Overall, 60 patients underwent single-port LM, and the remaining 60 were treated with traditional 3-port LM.

Disclosures: This study was funded by the Liaoning Provincial Department of Science and Technology. The authors declared no conflict of interests.

Source: Jiang L et al. Front Oncol. 2021 Sep 24. doi: 10.3389/fonc.2021.722084.

Recommended Reading

Growth of uterine fibroids in postmenopausal women
MDedge ObGyn
Change in leiomyoma size during pregnancy not as prominent as commonly thought
MDedge ObGyn
Clinical impression that fibroids is a major risk factor for preterm birth needs reconsideration
MDedge ObGyn
Uterine fibroids: Comparative analysis of approaches to myomectomy
MDedge ObGyn
OAE improves outcomes in women with persistent symptoms after UAE for uterine fibroids
MDedge ObGyn
Distinct clinical characteristics and typical morphology distinguishes HLRCC and sporadic uterine leiomyomas
MDedge ObGyn
TVUS + SE presents a specific and sensitive technique for differential diagnosis of uterine fibroids and adenomyosis
MDedge ObGyn
The influence of uterine fibroids on fertility in women planning to become pregnant
MDedge ObGyn
Clinical Edge Journal Scan Commentary: Uterine Fibroids October 2021
MDedge ObGyn
T2 relaxation time predicts effectiveness of MRgHIFU treatment of uterine fibroids
MDedge ObGyn